Late night on 16th February, Swiss pharma giant ‘Novartis’ has made a special announcement. Some things have been listed under this announcement. Strategic review of Novartis India Limited has been started. On the basis of which it can stop manufacturing medicines in India. In which its stake in the subsidiary company is being assessed. Exactly three months ago, UK’s big company AstraZeneca had also announced that it may exit the drug manufacturing company in India on the basis of Global Strategic Review. These announcements follow the pattern in which pharma…
Read MoreMany foreign pharmaceutical companies manufacturing medicines in India may be closed soon, this is the reason
